{"id":68745,"date":"2026-02-20T17:22:38","date_gmt":"2026-02-20T17:22:38","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=68745"},"modified":"2026-05-21T07:14:12","modified_gmt":"2026-05-21T07:14:12","slug":"bpc-157","status":"publish","type":"product","link":"https:\/\/medsbase.com\/hu\/product\/bpc-157\/","title":{"rendered":"BPC-157"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">Quick Answer \u2014 What is BPC-157?<\/h3>\n<p style=\"margin: 0;\"><strong>BPC-157<\/strong> (Body Protection Compound 157) is a 15-amino-acid synthetic pentadecapeptide derived from a protective gastric protein. In published preclinical research it has shown consistent effects on tendon, ligament, gut, muscle, and vascular tissue recovery via VEGF, nitric oxide, and growth-hormone-receptor signaling. Supplied in 2\u00a0mg to 10\u00a0mg lyophilized vials for laboratory research use only.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Mit kapsz a MedsBase-n\u00e1l:<\/strong> Kutat\u00e1si min\u0151s\u00e9g\u0171 liofiliz\u00e1lt peptidok \u00b7 HPLC \u226599% tisztas\u00e1g (tan\u00fas\u00edtv\u00e1ny k\u00e9r\u00e9sre) \u00b7 Diszkr\u00e9t, h\u0151m\u00e9rs\u00e9klet-stabil csomagol\u00e1s \u00b7 Vil\u00e1gszerte peptid fut\u00e1rszolg\u00e1lat \u00b7 1,400+ hiteles\u00edtett <a href=\"https:\/\/medsbase.com\/hu\/reviews\/\">v\u00e1s\u00e1rl\u00f3i v\u00e9lem\u00e9ny<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Minden rendel\u00e9st fedez a <a href=\"https:\/\/medsbase.com\/hu\/medsbase-re-shipment-assurance-policy\/\"><strong>\u00dajrak\u00fcld\u00e9si Garancia<\/strong><\/a> \u2014 ha a csomagod nem \u00e9rkezik meg 20 munkanapon bel\u00fcl, \u00fajrak\u00fcldj\u00fck.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Specifik\u00e1ci\u00f3<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">R\u00e9szlet<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>CAS sz\u00e1m<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">137525-51-0<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Molekul\u00e1ris k\u00e9plet<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>62<\/sub>H<sub>98<\/sub>N<sub>16<\/sub>O<sub>22<\/sub><\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Molekulat\u00f6meg<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">1419.55 Da<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Szekvencia<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (GEPPPGKPADDAGLV)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Forma<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Liofiliz\u00e1lt por (vagy a sz\u00e1ll\u00edtott form\u00e1ban)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Tisztas\u00e1g<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (HPLC-vel ellen\u0151rizve, COA ig\u00e9ny szerint)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>T\u00e1rol\u00e1s<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Liofiliz\u00e1lt: 2\u20138 \u00b0C (h\u0171t\u0151szekr\u00e9ny) munkak\u00e9szletk\u00e9nt; \u221220 \u00b0C hossz\u00fa t\u00e1v\u00fa t\u00e1rol\u00e1sra lez\u00e1ratlan \u00fcvegek eset\u00e9n. Rekonstitu\u00e1lt: 2\u20138 \u00b0C, haszn\u00e1lat ~30 napon bel\u00fcl. V\u00e9dj\u00fck a f\u00e9nyt\u0151l. Ne fagyassza-v\u00e1lassza fel az \u00fajra\u00e1ll\u00edtott oldatot.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Oldhat\u00f3s\u00e1g<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Bakt\u00e9riumstatikus v\u00edz (aj\u00e1nlott) vagy steril v\u00edz r\u00f6videbb haszn\u00e1latra<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Kutat\u00e1si c\u00e9lra<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Csak laborat\u00f3riumi kutat\u00e1si c\u00e9lra. Nem haszn\u00e1lhat\u00f3 hum\u00e1n vagy \u00e1llatgy\u00f3gy\u00e1szati diagnosztikai vagy ter\u00e1pi\u00e1s c\u00e9lra.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>What Is BPC-157?<\/h2>\n<p><strong>BPC-157<\/strong> is the abbreviation of <strong>Body Protection Compound 157<\/strong>, a 15-amino-acid synthetic pentadecapeptide originally isolated as a fragment of a larger protective protein found in human gastric juice. Unlike most peptides it is stable in gastric acid, which has made it a frequent subject of oral-administration research in rodent models alongside the more common subcutaneous route. BPC-157 is one of the most widely studied healing-research peptides in the preclinical literature, with published work spanning tendon, ligament, gut barrier, skeletal muscle, bone, and vascular tissue.<\/p>\n<p>The peptide sequence is GEPPPGKPADDAGLV, molecular weight approximately 1,419\u00a0Da, empirical formula C<sub>62<\/sub>H<sub>98<\/sub>N<sub>16<\/sub>O<sub>22<\/sub>. It is supplied as a high-purity lyophilized powder for reconstitution with bacteriostatic water. BPC-157 is <strong>laborat\u00f3riumi kutat\u00e1si c\u00e9lra szolg\u00e1l<\/strong> and is not intended for human or veterinary diagnosis or therapy. For a deep-dive on mechanism, published trial detail, and research-dosing considerations, see our full <a href=\"https:\/\/medsbase.com\/hu\/bpc-157-peptide-healing-recovery-guide\/\">BPC-157 kutat\u00e1si \u00fatmutat\u00f3<\/a>.<\/p>\n<h2>Mechanism of Action \u2014 Three Overlapping Healing Pathways<\/h2>\n<p>What differentiates BPC-157 from single-pathway peptides is its <strong>simultaneous activity across three distinct signaling routes<\/strong>, each contributing to the observed tissue-recovery phenotype in published research:<\/p>\n<ul>\n<li><strong>Angiogenesis \/ VEGF upregulation<\/strong> \u2014 BPC-157 upregulates vascular endothelial growth factor receptor 2 (VEGFR2) expression in injured tissue, promoting the formation of new capillaries. This improves local perfusion at repair sites, the rate-limiting step in tendon, ligament, and muscle healing.<\/li>\n<li><strong>Nitric oxide (NO) pathway<\/strong> \u2014 BPC-157 enhances endothelial nitric oxide synthase (eNOS) activity and protects vascular endothelium against oxidative damage. In rodent models of portal hypertension, systemic vasoconstriction, and stomach ulcers, this effect is central to the compound&#8217;s protective action.<\/li>\n<li><strong>Growth hormone receptor upregulation<\/strong> \u2014 BPC-157 increases growth hormone receptor (GHR) expression on fibroblasts and tenocytes, enhancing collagen type I synthesis. This mechanism is thought to underlie the observed tendon-strength gains in Achilles and medial-collateral-ligament transection models.<\/li>\n<\/ul>\n<p>Because these three pathways converge on tissue that has been injured, BPC-157 produces faster and more complete recovery than single-pathway interventions in the same models. It is also notably well tolerated across the range of published doses, with minimal off-target signaling reported in toxicology research.<\/p>\n<h2>K\u00f6zz\u00e9tett kutat\u00e1si alkalmaz\u00e1sok<\/h2>\n<p>BPC-157 is used in laboratory research contexts that investigate:<\/p>\n<ul>\n<li><strong>Tendon and ligament injury recovery<\/strong> \u2014 Achilles tendon transection, medial collateral ligament rupture, rotator-cuff tear rodent models (Chang et al., J Appl Physiol 2011; Staresinic et al., J Orthop Res 2003)<\/li>\n<li><strong>Gut barrier integrity and ulcer research<\/strong> \u2014 gastric ulcer, colitis, and inflammatory-bowel-disease models; BPC-157&#8217;s gastric-derived origin is mechanistically relevant here (Sikiric et al., Curr Med Chem 2011)<\/li>\n<li><strong>Skeletal muscle regeneration<\/strong> \u2014 post-injury recovery kinetics, myoblast proliferation, and myotube formation research<\/li>\n<li><strong>Joint and cartilage research<\/strong> \u2014 osteoarthritis rodent models, cartilage matrix composition, synovial inflammation<\/li>\n<li><strong>Vascular angiogenesis<\/strong> \u2014 new-capillary formation and perfusion at injured-tissue sites<\/li>\n<li><strong>Bone healing<\/strong> \u2014 fracture callus formation in osteotomy and bone-defect research models<\/li>\n<li><strong>Comparative recovery research<\/strong> \u2014 benchmarking against other healing peptides, especially <a href=\"https:\/\/medsbase.com\/hu\/tb-500\/\">TB-500 (Thymosin Beta-4)<\/a> as the canonical systemic healing comparator. See the <a href=\"https:\/\/medsbase.com\/hu\/bpc-157-vs-tb-500-comparison-guide\/\">BPC-157 vs TB-500 \u00f6sszehasonl\u00edt\u00e1s<\/a> for a full side-by-side.<\/li>\n<\/ul>\n<p>For broader context on where BPC-157 fits within the healing-peptide landscape, see <a href=\"https:\/\/medsbase.com\/hu\/best-peptides-for-muscle-recovery\/\">the best peptides for muscle recovery<\/a> cluster article and <a href=\"https:\/\/medsbase.com\/hu\/ghk-cu\/\">GHK-Cu copper peptide<\/a> as a complementary anti-aging research compound. Browse the full <a href=\"https:\/\/medsbase.com\/hu\/peptides\/\">kutat\u00e1si peptidek katal\u00f3gust<\/a> kapcsol\u00f3d\u00f3 vegy\u00fcletek\u00e9rt.<\/p>\n<h2>El\u00e9rhet\u0151 er\u0151ss\u00e9gek \u00e9s koncentr\u00e1ci\u00f3k<\/h2>\n<p>MedsBase stocks BPC-157 in the following lyophilized vial sizes. Each variation ships in 10-vial, 20-vial, and 30-vial pack formats with full reconstitution guidance:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Ampulla er\u0151ss\u00e9ge<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Tipikus felhaszn\u00e1l\u00e1si ter\u00fclet<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Csomagm\u00e9ret<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>2\u00a0mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Short research protocols, pilot dosing, titration<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 vagy 30 ampulla<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Szabv\u00e1nyos kutat\u00e1si er\u0151ss\u00e9g, leggyakrabban rendelt<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 vagy 30 ampulla<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Extended research protocols, lowest per-mg cost<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 vagy 30 ampulla<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>All three strengths are the same chemical form (lyophilized powder, 99%+ HPLC purity). Higher-mg vials require smaller reconstitution volumes per unit dose, which is useful when researchers want to minimise injection volume in rodent protocols.<\/p>\n<h2>How It Compares \u2014 BPC-157 vs TB-500<\/h2>\n<p>BPC-157 and <a href=\"https:\/\/medsbase.com\/hu\/tb-500\/\">TB-500<\/a> are the two most-cited healing-research peptides. They are often studied in parallel because they act via complementary, largely non-overlapping mechanisms. Many preclinical protocols combine them rather than using either alone.<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Krit\u00e9rium<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">BPC-157<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">TB-500 (Thymosin Beta-4)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Hossz<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">15 amino acids (pentadecapeptide)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">43 amino acids (thymic peptide)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Primary mechanism<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">VEGF + NO + GH receptor upregulation<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">G-actin sequestration, cell migration<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Distribution<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">More localized at injection site<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Systemic, distributes widely<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Tipikus kutat\u00e1si adag<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">250\u2013500\u00a0mcg, 1\u20132x daily<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">2\u20132.5\u00a0mg, 2x weekly<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Legjelent\u0151sebb kutat\u00e1si eredm\u00e9ny<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Tendon, ligament, gut barrier<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Cardiac, systemic muscle, vascular<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Stackel\u00e9s<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Commonly co-administered with TB-500 in research<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Commonly co-administered with BPC-157 in research<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>For a full methodological comparison including dosing protocols and when researchers pick one over the other, read <a href=\"https:\/\/medsbase.com\/hu\/bpc-157-vs-tb-500-comparison-guide\/\">BPC-157 vs TB-500: which healing peptide for your recovery goal<\/a>.<\/p>\n<h2>T\u00e1rol\u00e1s \u00e9s rekonstit\u00faci\u00f3<\/h2>\n<p><strong>Rekonstit\u00faci\u00f3 el\u0151tt:<\/strong> store lyophilized vials refrigerated at 2\u20138\u00a0\u00b0C in original packaging. Lyophilized BPC-157 is stable under these conditions for up to 36 months. Avoid freeze-thaw cycles on the powder.<\/p>\n<p><strong>Rekonstit\u00faci\u00f3s elj\u00e1r\u00e1s:<\/strong> inject bacteriostatic water down the side wall of the peptide vial (not directly onto the lyophilized cake) per the dilution table above. Swirl gently \u2014 do <strong>nem<\/strong> r\u00e1zuk meg \u2013 \u00e9s hagyjunk 2\u20135 percet a teljes old\u00f3d\u00e1sra. A helyesen rekonstitu\u00e1lt oldat tiszta \u00e9s sz\u00edntelen legyen.<\/p>\n<p><strong>Rekonstit\u00faci\u00f3 ut\u00e1n:<\/strong> store refrigerated at 2\u20138\u00a0\u00b0C and use within 30 days for optimal stability. Do not freeze reconstituted solution \u2014 freeze-thaw cycles degrade peptide integrity. Discard any vial showing cloudiness, precipitate, or discolouration.<\/p>\n<h2 id=\"faqs\">Gyakran Ism\u00e9telt K\u00e9rd\u00e9sek<\/h2>\n<h3>What is BPC-157 used for in research?<\/h3>\n<p>BPC-157 is used in laboratory research investigating tendon and ligament healing, gut barrier integrity, skeletal muscle recovery, vascular angiogenesis, anti-inflammatory signaling, and bone healing. It is <strong>nem<\/strong> FDA-approved and is sold here strictly for laboratory research use only.<\/p>\n<h3>How is BPC-157 different from TB-500?<\/h3>\n<p>BPC-157 is a 15-amino-acid pentadecapeptide derived from gastric juice, acting mostly locally via VEGF, nitric oxide, and growth-hormone-receptor pathways. TB-500 is a 43-amino-acid thymic peptide that acts systemically via G-actin binding and cell migration. The two are often co-administered in research because their mechanisms are complementary rather than overlapping.<\/p>\n<h3>What is the typical BPC-157 research dose?<\/h3>\n<p>Published preclinical protocols typically use 250\u2013500\u00a0mcg per administration, given once or twice daily for 4\u20138 week cycles. A 5\u00a0mg vial reconstituted with 2.0\u00a0mL bacteriostatic water yields 2.5\u00a0mg\/mL \u2014 10 ticks on a U-100 syringe equals 250\u00a0mcg.<\/p>\n<h3>Is BPC-157 FDA approved?<\/h3>\n<p>No. BPC-157 is not approved by the FDA, EMA, MHRA, or any other regulator for human therapeutic use. All BPC-157 sold by research-use-only suppliers is for laboratory investigation and should not be administered to humans.<\/p>\n<h3>How should BPC-157 be stored?<\/h3>\n<p>Liofiliz\u00e1lt ampull\u00e1k: 2\u20138 \u00b0C-on h\u0171tve, eredeti csomagol\u00e1sban, ak\u00e1r 36 h\u00f3napig stabil. Rekonstitu\u00e1lt oldat: 2\u20138 \u00b0C-on h\u0171tve, 30 napon bel\u00fcl haszn\u00e1lja fel. Ne fagyassza a rekonstitu\u00e1lt oldatot \u2013 a fagyaszt\u00e1s-olvad\u00e1s ciklusok k\u00e1ros\u00edtj\u00e1k a peptidet.<\/p>\n<h3>How do I reconstitute BPC-157?<\/h3>\n<p>Follow the reconstitution reference chart above. Add bacteriostatic water down the side wall of the vial (not onto the lyophilized cake), swirl gently, and allow 2\u20135 minutes for full dissolution. Do <strong>nem<\/strong> shake the vial.<\/p>\n<h3>Milyen er\u0151ss\u00e9g\u0171 k\u00e9sz\u00edtm\u00e9nyeket tart k\u00e9szleten a MedsBase?<\/h3>\n<p>MedsBase carries BPC-157 in 2\u00a0mg, 5\u00a0mg, and 10\u00a0mg lyophilized vials. Each strength is available in 10-vial, 20-vial, or 30-vial pack sizes. All vials are supplied at 99%+ HPLC purity with a certificate of analysis available on request.<\/p>\n<h3>Can BPC-157 and TB-500 be stacked in research?<\/h3>\n<p>Yes. BPC-157 and TB-500 are frequently co-administered in preclinical research because their mechanisms are complementary. BPC-157 acts mostly locally via growth-factor upregulation; TB-500 acts systemically via G-actin binding and cell migration. Combined protocols are described in our <a href=\"https:\/\/medsbase.com\/hu\/bpc-157-vs-tb-500-comparison-guide\/\">comparison guide<\/a>.<\/p>\n<h3>Does BPC-157 cause side effects in research?<\/h3>\n<p>Published preclinical research across rodent species has reported a notably clean safety profile at typical research doses, with no consistent off-target signals and good tolerability. Long-term human safety data are not available because human trials have not been completed.<\/p>\n<h3>What is the difference between oral and injectable BPC-157 in research?<\/h3>\n<p>BPC-157 is unusually stable in gastric acid due to its gastric-juice-derived origin, so oral administration is feasible in rodent protocols (unlike most peptides). Subcutaneous injection remains the most common research route in the literature because it produces more reproducible plasma concentrations.<\/p>\n<h3>What is the half-life of BPC-157?<\/h3>\n<p>In preclinical research, BPC-157 has an estimated plasma half-life of approximately 4 hours following subcutaneous administration. Oral route studies in rodent models suggest shorter systemic clearance but sustained local effects within the gastrointestinal tract, attributed to the peptide&#8217;s unusual acid-stability.<\/p>\n<h3>How long does BPC-157 take to show effects in preclinical research?<\/h3>\n<p>Most preclinical studies using BPC-157 in tendon, ligament, and gut injury models report measurable tissue-level changes within 7\u201314 days. The time-course varies with the research model, injury severity, route of administration, and dose used in the study design.<\/p>\n<h3>Can I order BPC-157 for international shipping?<\/h3>\n<p>Yes. MedsBase ships BPC-157 worldwide from our dedicated peptide shipping network. Peptide-only orders qualify for our standalone peptide shipping service. All orders ship in temperature-controlled packaging with full tracking.<\/p>\n<p class=\"medsbase-bundle-link-2026-05-01\" data-marker=\"mb-bundle-link-peptide-healing-stack\">BPC-157 protocols for tendon, ligament, and soft-tissue recovery typically pair it with TB-500 for synergistic angiogenic + cytoskeletal effects; for the bundled regimen see our <a href=\"\/hu\/peptide-healing-stack\/\">Peptide Gy\u00f3gy\u00edt\u00f3 Stack (BPC-157 5 mg + TB-500 5 mg + bakteriostatikus v\u00edz)<\/a> with both lyophilised vials and reconstitution water in one parcel at $0 peptide-shipping rate.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h2>Egy\u00e9b peptidok a regener\u00e1ci\u00f3 \u00e9s teljes\u00edtm\u00e9ny kutat\u00e1s\u00e1hoz<\/h2>\n<ul>\n<li><a href=\"\/hu\/tb-500\/\"><strong>TB-500<\/strong><\/a> \u2014 Thymosin Beta-4 fragmentum \u2014 l\u00e1gy sz\u00f6vetek \u00e9s \u00e9rrendszer regener\u00e1ci\u00f3s kutat\u00e1s<\/li>\n<li><a href=\"\/hu\/ipamorelin\/\"><strong>Ipamorelin<\/strong><\/a> \u2014 Szelekt\u00edv ghrelin agonist \u2014 tiszta GH impulzus kortizol\/prolaktin n\u00e9lk\u00fcl<\/li>\n<li><a href=\"\/hu\/cjc-1295-with-dac\/\"><strong>CJC-1295 with DAC<\/strong><\/a> \u2014 GHRH anal\u00f3g meghosszabb\u00edtott felez\u00e9si id\u0151vel<\/li>\n<li><a href=\"\/hu\/ghk-cu\/\"><strong>GHK-Cu<\/strong><\/a> \u2014 R\u00e9zpeptid \u2014 b\u0151r \u00e9s k\u00f6t\u0151sz\u00f6vet regener\u00e1ci\u00f3s kutat\u00e1s<\/li>\n<li><a href=\"\/hu\/igf-1-lr3\/\"><strong>IGF-1 LR3<\/strong><\/a> \u2014 Long-R3 IGF-1 analog \u2014 anabolic \/ regenerative research<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Tov\u00e1bbi olvasnival\u00f3<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Ismerd meg a peptid m\u00f6g\u00f6tt \u00e1ll\u00f3 kutat\u00e1st<\/strong><\/p>\n<p style=\"margin: 0;\">Olvasd el teljes, bizony\u00edt\u00e9kokon alapul\u00f3 \u00fatmutat\u00f3nkat: <a href=\"https:\/\/medsbase.com\/hu\/bpc-157-peptide-healing-recovery-guide\/\"><strong>BPC-157 \u2014 mechanism, trial data &amp; outlook<\/strong><\/a>. Le\u00edrja a hat\u00e1smechanizmust, publik\u00e1lt tanulm\u00e1nyadatokat, tipikus kutat\u00e1si d\u00f3zistartom\u00e1nyokat, rekonstit\u00faci\u00f3s protokollokat, kombin\u00e1l\u00e1si lehet\u0151s\u00e9geket \u00e9s biztons\u00e1gi\/ellenv\u00e9teli megjegyz\u00e9seket.<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Supports cellular regeneration<br \/>\n\u2705 Enhances tissue modeling<br \/>\n\u2705 Promotes fibroblast activity<br \/>\n\u2705 Stimulates angiogenic signaling<br \/>\n\u2705 Improves extracellular matrix stability<\/p>\n<p><strong>BPC-157<\/strong> szintetikus peptidvegy\u00fcletet tartalmaz.<\/p>","protected":false},"featured_media":70942,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[5440,5430,5441],"class_list":{"0":"post-68745","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-peptides","7":"product_tag-bpc-157","8":"product_tag-bpc-157-peptide","9":"product_tag-peptide","11":"first","12":"instock","13":"shipping-taxable","14":"purchasable","15":"product-type-variable","16":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product\/68745","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/comments?post=68745"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/media\/70942"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/media?parent=68745"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product_brand?post=68745"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product_cat?post=68745"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product_tag?post=68745"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}